Genome silencer therapy leading to 'regression' of cardiac amyloid load on cardiovascular magnetic resonance: a case report.

Florian, Anca; Bietenbeck, Michael; Hüsing-Kabar, Anna; Schilling, Matthias; Schmidt, Hartmut H; Yilmaz, Ali

Florian, Anca; Bietenbeck, Michael; Hüsing-Kabar, Anna; Schilling, Matthias; Schmidt, Hartmut H; Yilmaz, Ali.

Afiliación

Florian A; Department of Cardiology I, Division of Cardiovascular Imaging, University Hospital Münster, Albert-Schweitzer-Campus 1, Building A1, 48149 Münster, Germany.
Bietenbeck M; Department of Cardiology I, Division of Cardiovascular Imaging, University Hospital Münster, Albert-Schweitzer-Campus 1, Building A1, 48149 Münster, Germany.
Hüsing-Kabar A; Department of Gastroenterology/Hepatology, University Hospital Münster, Münster, Germany.
Schilling M; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Germany.
Schmidt HH; Department of Gastroenterology/Hepatology, University Hospital Münster, Münster, Germany.
Yilmaz A; Department of Cardiology I, Division of Cardiovascular Imaging, University Hospital Münster, Albert-Schweitzer-Campus 1, Building A1, 48149 Münster, Germany.

Eur Heart J Case Rep ; 5(11): ytab415, 2021 Nov.

Article en En | MEDLINE | ID: mdl-34816083

Palabras clave

ATTR; Amyloidosis; CMR; Case report; Inotersen; LGE; Patisiran

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Eur Heart J Case Rep Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google